Global Dental Bone Graft Substitute Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

Description

List of Tables

The global demand for Dental Bone Graft Substitute Market is presumed to reach the market size of nearly USD 1082.44 MN by 2030 from USD 567.77 MN in 2022 with a CAGR of 8.4% under the study period 2023 - 2030.

A Dental bone graft substitute is a medical material used in dental procedures to replace or augment bone tissue in the oral and maxillofacial regions. This substitute serves as a scaffold that supports the growth of new bone, aiding in the regeneration of bone tissue and facilitating various dental procedures.

MARKET DYNAMICS:

The Dental bone graft substitute market is propelled by several factors that contribute to its expansion in various dental procedures. With the growing popularity of dental implants and the need for robust bone support, the market benefits from the rise in dental implant procedures. An aging global population seeking solutions for tooth loss and bone resorption further drives demand, especially for aesthetic dental restorations. Advancements in bone grafting materials and technologies like 3D printing enhance treatment precision, while the focus on regenerative medicine principles aligns with the natural healing and regeneration processes. The prevalence of periodontal diseases, increasing dental tourism, and the trend toward minimally invasive procedures also contribute to market growth. Government support and the growth of dental clinics and practices further boost adoption. Overall, the Dental bone graft substitute market is shaped by evolving patient demands, technological innovations, and the drive for effective, aesthetically pleasing dental solutions.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of dental bone graft substitute. The growth and trends of dental bone graft substitute industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the dental bone graft substitute market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

Synthetic Bone Graft
Xenograft
Allograft
Autograft
Alloplast
Demineralized Allograft
Others

By Application

Socket Preservation
Ridge Augmentation
Periodontal Defect Regeneration
Implant Bone Regeneration
Sinus Lift

By Mechanism

Osteoconduction
Osteoinduction
Osteopromotion
Osteogenesis

By Product

Bio OSS
Osteograf
Grafton

By End Users

Hospitals
Dental Clinics
Others

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Dental Bone Graft Substitute market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Dental Bone Graft Substitute market include Dentsply Sirona (US), Johnson & Johnson (US), Danaher Corporation (US), Medtronic (Ireland), Strauman (US), Zimmer Dental (US), Geistlich Pharm (Switzerland), RTI Surgical (US), BioHorizons, IPH, Inc (US), Dentium (South Korea), LifeSciences Corporation (US), Smith & Nephew (UK), Novabone LLC (US), Botiss biomaterials GmbH (US), Collagen Matrix Inc. (US), Osteogenics Biomedical (US), LifeNet Health (US), Wright Medical (US), and Stryker Corporation (US). This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Product Code: VMR112112086

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . DENTAL BONE GRAFT SUBSTITUTE - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Type
- 3.7.2 Market Attractiveness Analysis By Application
- 3.7.3 Market Attractiveness Analysis By Mechanism
- 3.7.4 Market Attractiveness Analysis By Product
- 3.7.5 Market Attractiveness Analysis By End Users
- 3.7.6 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . GLOBAL DENTAL BONE GRAFT SUBSTITUTE MARKET ANALYSIS BY TYPE

5.1 Overview by Type
5.2 Historical and Forecast Data
5.3 Analysis by Type
5.4 Synthetic Bone Graft Historic and Forecast Sales by Regions
5.5 Xenograft Historic and Forecast Sales by Regions
5.6 Allograft Historic and Forecast Sales by Regions
5.7 Autograft Historic and Forecast Sales by Regions
5.8 Alloplast Historic and Forecast Sales by Regions
5.9 Demineralized Allograft Historic and Forecast Sales by Regions
5.10. Others Historic and Forecast Sales by Regions

6 . GLOBAL DENTAL BONE GRAFT SUBSTITUTE MARKET ANALYSIS BY APPLICATION

6.1 Overview by Application
6.2 Historical and Forecast Data
6.3 Analysis by Application
6.4 Socket Preservation Historic and Forecast Sales by Regions
6.5 Ridge Augmentation Historic and Forecast Sales by Regions
6.6 Periodontal Defect Regeneration Historic and Forecast Sales by Regions
6.7 Implant Bone Regeneration Historic and Forecast Sales by Regions
6.8 Sinus Lift Historic and Forecast Sales by Regions

7 . GLOBAL DENTAL BONE GRAFT SUBSTITUTE MARKET ANALYSIS BY MECHANISM

7.1 Overview by Mechanism
7.2 Historical and Forecast Data
7.3 Analysis by Mechanism
7.4 Osteoconduction Historic and Forecast Sales by Regions
7.5 Osteoinduction Historic and Forecast Sales by Regions
7.6 Osteopromotion Historic and Forecast Sales by Regions
7.7 Osteogenesis Historic and Forecast Sales by Regions

8 . GLOBAL DENTAL BONE GRAFT SUBSTITUTE MARKET ANALYSIS BY PRODUCT

8.1 Overview by Product
8.2 Historical and Forecast Data
8.3 Analysis by Product
8.4 Bio OSS Historic and Forecast Sales by Regions
8.5 Osteograf Historic and Forecast Sales by Regions
8.6 Grafton Historic and Forecast Sales by Regions

9 . GLOBAL DENTAL BONE GRAFT SUBSTITUTE MARKET ANALYSIS BY END USERS

9.1 Overview by End Users
9.2 Historical and Forecast Data
9.3 Analysis by End Users
9.4 Hospitals Historic and Forecast Sales by Regions
9.5 Dental Clinics Historic and Forecast Sales by Regions
9.6 Others Historic and Forecast Sales by Regions

10 . GLOBAL DENTAL BONE GRAFT SUBSTITUTE MARKET ANALYSIS BY GEOGRAPHY

10.1. Regional Outlook
10.2. Introduction
10.3. North America Sales Analysis
- 10.3.1. Overview, Historic and Forecast Data Sales Analysis
- 10.3.2. North America By Segment Sales Analysis
- 10.3.3. North America By Country Sales Analysis
- 10.3.4. United State Sales Analysis
- 10.3.5. Canada Sales Analysis
- 10.3.6. Mexico Sales Analysis
10.4. Europe Sales Analysis
- 10.4.1. Overview, Historic and Forecast Data Sales Analysis
- 10.4.2. Europe by Segment Sales Analysis
- 10.4.3. Europe by Country Sales Analysis
- 10.4.4. United Kingdom Sales Analysis
- 10.4.5. France Sales Analysis
- 10.4.6. Germany Sales Analysis
- 10.4.7. Italy Sales Analysis
- 10.4.8. Russia Sales Analysis
- 10.4.9. Rest Of Europe Sales Analysis
10.5. Asia Pacific Sales Analysis
- 10.5.1. Overview, Historic and Forecast Data Sales Analysis
- 10.5.2. Asia Pacific by Segment Sales Analysis
- 10.5.3. Asia Pacific by Country Sales Analysis
- 10.5.4. China Sales Analysis
- 10.5.5. India Sales Analysis
- 10.5.6. Japan Sales Analysis
- 10.5.7. South Korea Sales Analysis
- 10.5.8. Australia Sales Analysis
- 10.5.9. South East Asia Sales Analysis
- 10.5.10. Rest Of Asia Pacific Sales Analysis
10.6. Latin America Sales Analysis
- 10.6.1. Overview, Historic and Forecast Data Sales Analysis
- 10.6.2. Latin America by Segment Sales Analysis
- 10.6.3. Latin America by Country Sales Analysis
- 10.6.4. Brazil Sales Analysis
- 10.6.5. Argentina Sales Analysis
- 10.6.6. Peru Sales Analysis
- 10.6.7. Chile Sales Analysis
- 10.6.8. Rest of Latin America Sales Analysis
10.7. Middle East & Africa Sales Analysis
- 10.7.1. Overview, Historic and Forecast Data Sales Analysis
- 10.7.2. Middle East & Africa by Segment Sales Analysis
- 10.7.3. Middle East & Africa by Country Sales Analysis
- 10.7.4. Saudi Arabia Sales Analysis
- 10.7.5. UAE Sales Analysis
- 10.7.6. Israel Sales Analysis
- 10.7.7. South Africa Sales Analysis
- 10.7.8. Rest Of Middle East And Africa Sales Analysis

11 . COMPETITIVE LANDSCAPE OF THE DENTAL BONE GRAFT SUBSTITUTE COMPANIES

11.1. Dental Bone Graft Substitute Market Competition
11.2. Partnership/Collaboration/Agreement
11.3. Merger And Acquisitions
11.4. New Product Launch
11.5. Other Developments

12 . COMPANY PROFILES OF DENTAL BONE GRAFT SUBSTITUTE INDUSTRY

12.1. Company Share Analysis
12.2. Market Concentration Rate
12.3. Dentsply Sirona (US)
- 12.3.1. Company Overview
- 12.3.2. Company Revenue
- 12.3.3. Products
- 12.3.4. Recent Developments
12.4. Johnson & Johnson (US)
- 12.4.1. Company Overview
- 12.4.2. Company Revenue
- 12.4.3. Products
- 12.4.4. Recent Developments
12.5. Danaher Corporation (US)
- 12.5.1. Company Overview
- 12.5.2. Company Revenue
- 12.5.3. Products
- 12.5.4. Recent Developments
12.6. Medtronic (Ireland)
- 12.6.1. Company Overview
- 12.6.2. Company Revenue
- 12.6.3. Products
- 12.6.4. Recent Developments
12.7. Strauman (US)
- 12.7.1. Company Overview
- 12.7.2. Company Revenue
- 12.7.3. Products
- 12.7.4. Recent Developments
12.8. Zimmer Dental (US)
- 12.8.1. Company Overview
- 12.8.2. Company Revenue
- 12.8.3. Products
- 12.8.4. Recent Developments
12.9. Geistlich Pharm (Switzerland)
- 12.9.1. Company Overview
- 12.9.2. Company Revenue
- 12.9.3. Products
- 12.9.4. Recent Developments
12.10. RTI Surgical (US)
- 12.10.1. Company Overview
- 12.10.2. Company Revenue
- 12.10.3. Products
- 12.10.4. Recent Developments
12.11. BioHorizons
- 12.11.1. Company Overview
- 12.11.2. Company Revenue
- 12.11.3. Products
- 12.11.4. Recent Developments
12.12. IPH Inc (US)
- 12.12.1. Company Overview
- 12.12.2. Company Revenue
- 12.12.3. Products
- 12.12.4. Recent Developments
12.13. Dentium (South Korea)
- 12.13.1. Company Overview
- 12.13.2. Company Revenue
- 12.13.3. Products
- 12.13.4. Recent Developments
12.14. LifeSciences Corporation (US)
- 12.14.1. Company Overview
- 12.14.2. Company Revenue
- 12.14.3. Products
- 12.14.4. Recent Developments
12.15. Smith & Nephew (UK)
- 12.15.1. Company Overview
- 12.15.2. Company Revenue
- 12.15.3. Products
- 12.15.4. Recent Developments
12.16. Novabone LLC (US)
- 12.16.1. Company Overview
- 12.16.2. Company Revenue
- 12.16.3. Products
- 12.16.4. Recent Developments
12.17. Botiss biomaterials GmbH (US)
- 12.17.1. Company Overview
- 12.17.2. Company Revenue
- 12.17.3. Products
- 12.17.4. Recent Developments
12.18. Collagen Matrix Inc. (US)
- 12.18.1. Company Overview
- 12.18.2. Company Revenue
- 12.18.3. Products
- 12.18.4. Recent Developments
12.19. Osteogenics Biomedical (US)
- 12.19.1. Company Overview
- 12.19.2. Company Revenue
- 12.19.3. Products
- 12.19.4. Recent Developments
12.20. LifeNet Health (US)
- 12.20.1. Company Overview
- 12.20.2. Company Revenue
- 12.20.3. Products
- 12.20.4. Recent Developments
12.21. Wright Medical (US)
- 12.21.1. Company Overview
- 12.21.2. Company Revenue
- 12.21.3. Products
- 12.21.4. Recent Developments
12.22. Stryker Corporation (US)
- 12.22.1. Company Overview
- 12.22.2. Company Revenue
- 12.22.3. Products
- 12.22.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies